Literature DB >> 1986604

Heterotopic pregnancies after in vitro fertilization and embryo transfer.

B Rizk1, S L Tan, S Morcos, A Riddle, P Brinsden, B A Mason, R G Edwards.   

Abstract

Seventeen cases of heterotopic pregnancies are reported among 1648 clinical pregnancies after in vitro fertilization. The high prevalence of tubal damage among IVF patients and the use of superovulation and multiple embryo transfer might predispose patients to the condition. Nine patients reported abdominal pain and vaginal bleeding, five patients did not have symptoms, and three had acute abdominal emergencies. Transvaginal ultrasonography was superior to transabdominal ultrasonography in the diagnosis of extrauterine pregnancies. The presence of an intrauterine gestation sac in a patient without symptoms should not exclude the diagnosis of a concomitant extrauterine pregnancy until the pelvis is carefully visualized. Early diagnoses of viable ectopic pregnancies before rupture abolishes mortality and morbidity and offers the chance of patient selection for conservative treatment. In two patients the extrauterine gestation sac was treated by transvaginal aspiration and injection of potassium chloride under ultrasonographic guidance. The outcome of the intrauterine pregnancy was favorable regardless of the method of treatment of the ectopic pregnancy.

Entities:  

Mesh:

Year:  1991        PMID: 1986604     DOI: 10.1016/0002-9378(91)90648-b

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Impact of technical difficulties, choice of catheter, and the presence of blood on the success of embryo transfer--experience from a single provider.

Authors:  Hassan N Sallam; Abdel Fattah Agameya; Ashraf Farrag Rahman; Fathy Ezzeldin; Ahmed N Sallam
Journal:  J Assist Reprod Genet       Date:  2003-04       Impact factor: 3.412

2.  Ectopic pregnancies after in vitro fertilization and embryo transfer.

Authors:  E Pyrgiotis; K M Sultan; G S Neal; H C Liu; J A Grifo; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

Review 3.  Heterotopic pregnancy and assisted reproduction--an update.

Authors:  N Rojansky; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1996-08       Impact factor: 3.412

Review 4.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

5.  OVARIAN HYPERSTIMULATION SYNDROME DURING INDUCTION OF OVULATION FOR INTRA UTERINE INSEMINATION.

Authors:  S K Rath; R K Sharma; P Tarneja; A B Chattopadhyay; R D Wadhwa
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Heterotopic pregnancy following induction of ovulation with clomiphene citrate.

Authors:  Sedigheh Ghandi; Raheleh Ahmadi; Mahmoud Fazel
Journal:  Iran J Reprod Med       Date:  2011

7.  Recurrent heterotopic pregnancy after bilateral salpingectomy in an IVF patient: case report.

Authors:  I Ben-Ami; M Panski; F Ushakov; Z Vaknin; A Herman; A Raziel
Journal:  J Assist Reprod Genet       Date:  2006-07-06       Impact factor: 3.412

8.  Combined intrauterine triplet and ectopic pregnancy following pronuclear embryo transfer in a patient with elevated serum progesterone during ovulation induction.

Authors:  S Smith; L Scott; S Hosid
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

9.  Bilateral tubal pregnancies after the termination of intrauterine pregnancy following gamete intrafallopian transfer.

Authors:  Hiroaki Shibahara; Tatsuya Suzuki; Tomoaki Wada; Takashi Ohno; Ariko Yamauchi; Tetsuo Tsunoda; Satoru Takamizawa; Ikuo Sato; Satoshi Shiraishi
Journal:  Reprod Med Biol       Date:  2002-12-11

10.  The Risk Factors and Pregnancy Outcomes of 48 Cases of Heterotopic Pregnancy from a Single Center.

Authors:  Ji Hyun Jeon; Yu Im Hwang; Im Hee Shin; Chan Woo Park; Kwang Moon Yang; Hye Ok Kim
Journal:  J Korean Med Sci       Date:  2016-05-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.